Published in J Virol on August 01, 2001
Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase. J Virol (2004) 1.15
AZT-resistant foamy virus. Virology (2007) 0.83
Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res (1988) 32.89
Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science (1989) 15.19
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science (1992) 14.70
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J (1989) 10.84
Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science (1991) 8.76
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc Natl Acad Sci U S A (1993) 6.14
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides. Antimicrob Agents Chemother (1993) 5.08
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc Natl Acad Sci U S A (1995) 4.37
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol (1994) 3.85
Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47
Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine. J Virol (1992) 3.46
An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst (1971) 3.30
Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol (1988) 3.28
Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine. Antimicrob Agents Chemother (1992) 3.11
A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int Immunol (1993) 1.93
Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses (1995) 1.92
Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study. Proc Natl Acad Sci U S A (1993) 1.92
Evidence that the human foamy virus genome is DNA. J Virol (1999) 1.85
Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'-dideoxythymidine in cell culture. Antimicrob Agents Chemother (1994) 1.79
Foamy virus vectors. J Virol (1996) 1.72
Replication and regulation of primate foamy viruses. Virology (1991) 1.57
The structural and functional organization of H-NS-like proteins is evolutionarily conserved in gram-negative bacteria. Mol Microbiol (1999) 1.37
Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol (1999) 1.29
Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. J Virol (1998) 1.24
Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains. Virology (1995) 1.18
Helper-free foamy virus vectors. Hum Gene Ther (1998) 1.07
Stavudine resistance: an update on susceptibility following prolonged therapy. Antivir Ther (1999) 1.04
HIV-1 group O sensitivity to antiretroviral drugs. AIDS (1995) 1.01
The crystal structure of human eukaryotic release factor eRF1--mechanism of stop codon recognition and peptidyl-tRNA hydrolysis. Cell (2000) 3.92
First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill (2010) 3.86
Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet (1995) 3.81
Large-scale monitoring of pleiotropic regulation of gene expression by the prokaryotic nucleoid-associated protein, H-NS. Mol Microbiol (2001) 3.60
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet (1998) 3.45
Multiple control of flagellum biosynthesis in Escherichia coli: role of H-NS protein and the cyclic AMP-catabolite activator protein complex in transcription of the flhDC master operon. J Bacteriol (1999) 2.80
Arthropod-borne viruses transmitted by Phlebotomine sandflies in Europe: a review. Euro Surveill (2010) 2.78
A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob Agents Chemother (1998) 2.45
The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol Microbiol (1993) 2.39
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. J Antimicrob Chemother (2008) 2.17
Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol (1991) 2.16
Hepatitis C virus and essential mixed cryoglobulinaemia. Br J Rheumatol (1993) 2.08
Towards a better understanding of the genetic and physiological basis for nitrogen use efficiency in maize. Plant Physiol (2001) 2.01
Infection with Mayaro virus in a French traveller returning from the Amazon region, Brazil, January, 2010. Euro Surveill (2010) 1.94
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS (1999) 1.75
Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen. J Med Virol (2001) 1.68
The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis. Clin Infect Dis (1998) 1.67
Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2. Lancet (1988) 1.66
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle. Eur J Immunol (2000) 1.62
Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation (2000) 1.58
Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii. Antimicrob Agents Chemother (1998) 1.56
Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS (1999) 1.47
Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology (2000) 1.47
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut (1999) 1.44
antiphospholipid antibodies and RA: presence of beta2GP1 independent aCL. Ann Rheum Dis (2001) 1.44
Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol (1993) 1.39
Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups. J Immunol (2000) 1.39
Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA. Mol Microbiol (1994) 1.38
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology (1998) 1.37
Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med (1995) 1.34
Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob Agents Chemother (1997) 1.34
Role of Escherichia coli histone-like nucleoid-structuring protein in bacterial metabolism and stress response--identification of targets by two-dimensional electrophoresis. Eur J Biochem (1997) 1.33
Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology (1992) 1.32
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study. Lancet (2001) 1.32
Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. J Clin Microbiol (2009) 1.30
Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis. J Acquir Immune Defic Syndr (1992) 1.25
Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of American Kaposi's sarcoma with cytomegalovirus. Int J Cancer (1978) 1.25
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure. AIDS (2001) 1.24
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet (1995) 1.22
Identification of a novel hepatitis E virus in Nigeria. J Gen Virol (2000) 1.21
Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS (1992) 1.18
Directional persistence of chemotactic bacteria in a traveling concentration wave. Proc Natl Acad Sci U S A (2011) 1.17
Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases. Arch Dermatol (1998) 1.17
Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification. HIV Med (2007) 1.17
Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays. Hepatology (1999) 1.17
Characterization of polyamine synthesis pathway in Bacillus subtilis 168. Mol Microbiol (1998) 1.16
Fluoroquinolone induced tendinopathy: report of 6 cases. J Rheumatol (1996) 1.16
Mixed cryoglobulinemia and hepatitis C virus. Am J Med (1994) 1.15
Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J Virol (1994) 1.14
Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor. J Clin Microbiol (1999) 1.12
Restoration of the immune system with anti-retroviral therapy. Immunol Lett (1999) 1.12
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors. Antimicrob Agents Chemother (2001) 1.11
Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J Virol (1993) 1.11
Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals. Virology (2000) 1.08
Characterization of BpH3, an H-NS-like protein in Bordetella pertussis. Mol Microbiol (1997) 1.08
Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology (2001) 1.07
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication. AIDS (2005) 1.07
Puzzles concerning the pathogenicity of human herpesvirus 6. N Engl J Med (1993) 1.06
Antigenic and genetic differentiation of the two putative types of human herpes virus 6. J Virol Methods (1993) 1.06
Site-directed mutagenesis of residues 164, 170, 171, 179, 220, 237 and 242 in PER-1 beta-lactamase hydrolysing expanded-spectrum cephalosporins. Protein Eng (1999) 1.05
A locus involved in kanamycin, chloramphenicol and L-serine resistance is located in the bglY-galU region of the Escherichia coli K12 chromosome. Mol Gen Genet (1989) 1.05
Definition and distribution analysis of glycoprotein B gene alleles of human herpesvirus 7. J Virol (1998) 1.05
Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses (1996) 1.05
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. J Virol (2000) 1.05
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. AIDS (1999) 1.04
Stavudine resistance: an update on susceptibility following prolonged therapy. Antivir Ther (1999) 1.04
Relationship between inbreeding depression and inbreeding coefficient in maritime pine (Pinus pinaster). Theor Appl Genet (1996) 1.01
Isolation and characterization of vicH, encoding a new pleiotropic regulator in Vibrio cholerae. J Bacteriol (2000) 1.01
CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol (1998) 1.00
Antibody patterns to herpesviruses in kaposi's sarcoma: serological association of european kaposi's sarcoma with cytomegalovirus. Int J Cancer (1975) 1.00
Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol (1993) 1.00
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment. AIDS Res Hum Retroviruses (2000) 0.99
Recombination and rescue between temperature-sensitive mutants of poliovirus type 1. Virology (1984) 0.99
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. J Clin Microbiol (1999) 0.97
Simplified test for detecting the resistance of herpes simplex virus to acyclovir. J Med Virol (1990) 0.97
Frequency of early in utero HIV-1 infection: a blind DNA polymerase chain reaction study on 100 fetal thymuses. AIDS (1995) 0.97
Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains. J Clin Microbiol (2008) 0.97
Control of bacterial motility by environmental factors in polarly flagellated and peritrichous bacteria isolated from Lake Baikal. Appl Environ Microbiol (2001) 0.96